Skip to content
Life Sciences Series A Founded 2015

Roswell

Roswell Biotech develops biotechnology platforms integrating semiconductor technology with molecular biology for life science applications. The company creates innovative biosensor technologies that enable single-molecule detection and analysis at scale, bridging the gap between electronic readout and biological processes. Founded in 2015, headquartered in San Diego, United States, The company has raised $32.0M at…

📍 San Diego, United States · Genomics,

Funding snapshot

Last roundSeries A
Amount$32M
Date2 January 2019
Total raised$32M
Team size36

About

Roswell Biotech develops biotechnology platforms integrating semiconductor technology with molecular biology for life science applications. The company creates innovative biosensor technologies that enable single-molecule detection and analysis at scale, bridging the gap between electronic readout and biological processes. Founded in 2015, headquartered in San Diego, United States, The company has raised $32.0M at the Series A stage, backed by investors including PTK Capital, JAM Fund. The company operates in the Life Sciences > Genomics, Life Sciences > Life Sciences Platforms and Tools, Semiconductors > Sensors sector. with business models spanning Genomics > Enabling Technologies > Instrument Systems > Nucleic Acid Analysis > Sequencing, Life Sciences Platforms and Tools > Instruments > Genomics > Nucleic Acid Sequencing. serving markets in United States. Provider of diagnostic sensor solutions for nucleic acid sequencing..

Business model

Genomics > Enabling Technologies > Instrument Systems > Nucleic Acid Analysis > Sequencing,

Life Sciences Platforms and Tools > Instruments > Genomics > Nucleic Acid Sequencing,

Sensors > Generic Sensor Developers > Biological > Diagnostics

Institutional investors

PTK Capital JAM Fund

Latest coverage

No articles yet.

Raising like Roswell?

Analyze your pitch deck before your next raise.

Analyze My Deck →